Dobrinja Chiara, Trevisan Giuliano, Piscopello Lanfranco, Fava Maria, Liguori Gennaro
Istituto di Clinica Chirurgica Generale e Terapia Chirurgica, Dipartimento Universitario Clinico di Anestesia, Chirurgia, Anatomia Patologica, Dermatologia, Epatologia e Scienze Molecolari, Ospedale di Cattinara, Università degli Studi di Trieste, Italia.
Ann Ital Chir. 2010 Nov-Dec;81(6):403-10; discussion 410-1.
The objective of this study is to determine the optimal surgical approach for patients undergoing thyroid operation for indeterminate follicular lesions diagnosed by cytology and to evaluate the long-term outcome of patients treated by hemi or total thyroidectomy for these lesions.
From January 2000 to January 2010, 98 patients having a solitary thyroid nodule with a cytological diagnosis of "indeterminate follicular lesion" were selected retrospectively.
There were 81 women and 17 men with a mean age of 56 years (range: 28-83). Hemithyroidectomy (HT) was performed in 57 patients (58%) and a Total thyroidectomy (TT) in 41 (42%). Postoperative morbidity was 3.50% in patients who underwent HT and 9.75% in those who underwent TT At the histological analysis 16 (16.32%) patients had a malignant lesion.
HT was considered adequate treatment for 51 patients (89.48%) while in 6 patients (10.52%) has been necessary a completion thyroidectomy. Total thyroidectomy was not associated with clinically significant additive morbidity No permanent hypoparathyroidism and no definitive recurrent nerve palsies were observed in either group. Postoperative thyroid hormone replacement was required in 40.35% of lobectomy patients. Overall, in the indeterminate follicular lesions patient population, 57 hemithyroidectomies were performed and no further operation was required in about 90% of patients.
Considering the high rate in which HT represents the adequate treatment, and the low rate of re-operation morbidity, HT seems to be the preferable initial surgical approach for indeterminate follicular lesions. Long-term ultrasonographic follow-up seems advisable.
本研究的目的是确定接受甲状腺手术治疗经细胞学诊断为不确定滤泡性病变患者的最佳手术方式,并评估因这些病变接受半甲状腺切除术或全甲状腺切除术患者的长期预后。
回顾性选取2000年1月至2010年1月间98例有单个甲状腺结节且细胞学诊断为“不确定滤泡性病变”的患者。
81例女性和17例男性,平均年龄56岁(范围:28 - 83岁)。57例患者(58%)接受了半甲状腺切除术(HT),41例(42%)接受了全甲状腺切除术(TT)。接受HT的患者术后发病率为3.50%,接受TT的患者为9.75%。组织学分析显示,16例(16.32%)患者有恶性病变。
HT被认为是51例患者(89.48%)的充分治疗方式,而6例患者(10.52%)需要行甲状腺全切术。全甲状腺切除术未伴有具有临床意义的额外发病率。两组均未观察到永久性甲状旁腺功能减退和明确的喉返神经麻痹。40.35%的叶切除术患者术后需要甲状腺激素替代治疗。总体而言,在不确定滤泡性病变患者群体中,共进行了57例半甲状腺切除术,约90%的患者无需进一步手术。
考虑到HT作为充分治疗方式的高比例以及再次手术发病率低,HT似乎是不确定滤泡性病变首选的初始手术方式。长期超声随访似乎是可取的。